Plasma levels of carboxypeptidase U (CPU, CPB2 or TAFIa) are elevated in patients with acute myocardial infarction (Q58864163)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26340515%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Plasma levels of carboxypeptidase U (CPU, CPB2 or TAFIa) are elevated in patients with acute myocardial infarction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26340515%20AND%20SRC:MED&resulttype=core&format=json

acute myocardial infarction

23 February 2020

main subject

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26340515%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Anne-Marie Lambeir

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26340515%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

D Leenaerts

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26340515%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

J M Bosmans

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26340515%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Y Sim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26340515%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

D Hendriks

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26340515%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

12 November 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26340515%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thrombosis and Haemostasis

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26340515%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26340515%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

2227-2232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26340515%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26340515%20AND%20SRC:MED&resulttype=core&format=json

Thrombin generation in patients with a first acute myocardial infarction.

23 February 2020

cites work

1 reference

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

21 January 2018

1 reference

Measurement of procarboxypeptidase U (TAFI) in human plasma: a laboratory challenge

21 January 2018

1 reference

Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles

21 January 2018

1 reference

Insights into thrombin activatable fibrinolysis inhibitor function and regulation.

21 January 2018

1 reference

Measurement of carboxypeptidase U (active thrombin-activatable fibrinolysis inhibitor) in plasma: Challenges overcome by a novel selective assay

21 January 2018

1 reference

An assay for measuring functional activated thrombin-activatable fibrinolysis inhibitor in plasma.

21 January 2018

1 reference

21 January 2018

1 reference

2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribu

21 January 2018

1 reference

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

21 January 2018

1 reference

Development of a sensitive and selective assay for the determination of procarboxypeptidase U (thrombin-activatable fibrinolysis inhibitor) in plasma

21 January 2018

1 reference

An update on the role of carboxypeptidase U (TAFIa) in fibrinolysis

21 January 2018

1 reference

Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGenestudy

21 January 2018

1 reference

Carboxypeptidase U (TAFIa) prevents lysis from proceeding into the propagation phase through a threshold-dependent mechanism.

21 January 2018

1 reference

The intrinsic threshold of the fibrinolytic system is modulated by basic carboxypeptidases, but the magnitude of the antifibrinolytic effect of activated thrombin-activable fibrinolysis inhibitor is masked by its instability.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JTH.13135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26340515%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference